Product Images Vraylar

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Vraylar NDC 70518-3157 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Remedy_Label - Remedy Label

Remedy_Label - Remedy Label

Vraylar is a medication packaged in capsule form with a strength of 6 mg. It comes in a pack of 30 and is labeled as RX only. The source NDC for this medication is 61874-0160-30, and it is manufactured by Allergan, Inc. in Ivine, CA 92612. The lot number and expiry date are not available. The medication should be kept out of reach from children and stored between temperatures of 20-26°C (63-77°F) with excursions permitted to 15-30°C (59-86°F). The directions for use should be consulted in the package insert. This medication has been repackaged by RemedyRepack Inc. located in Indiana, PA 15701.*

MM2 - Vraylar 6mg 70518 3157 01

MM2 - Vraylar 6mg 70518 3157 01

Vraylar is a capsule containing 6 mg of Carlprazine. It is a prescription medication to be used as directed, and the package insert should be consulted for proper use. The NDC number is 70518-3157-01, and the medication was repackaged by RemedyRepack Inc. The manufacturer is Allergan, Inc. located in Ivine, California. The medication should be stored between 20-26°C (63-77°F) with permitted excursions to 15-30°C (59-86°F) in accordance with USP guidelines. Lot and expiration information is not available. It is important to keep this medication out of the reach of children.*

The chemical structure for VRAYLAR is cariprazine HCl, an atypical antipsychotic. The chemical name is trans-N-{4-[2-[4-(2,3 dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hyd - vraylar 01

The chemical structure for VRAYLAR is cariprazine HCl, an atypical antipsychotic. The chemical name is trans-N-{4-[2-[4-(2,3 dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N’,N’-dimethylurea hyd - vraylar 01

Figure 1. Plasma Concentration (Mean ± SE)-Time Profile During and Following12-weeks of Treatment with Cariprazine 6 mg/daya - vraylar 02

Figure 1.  Plasma Concentration (Mean ± SE)-Time Profile During and Following12-weeks of Treatment with Cariprazine 6 mg/daya - vraylar 02

Figure 2 Change from Baseline in PANSS total score by weekly visits (Study 2) - vraylar 03

Figure 2 Change from Baseline in PANSS total score by weekly visits (Study 2) - vraylar 03

Figure 3 Kaplan-Meier Curves of Cumulative Rate of Relapse During the Double-Blind Treatment Period - vraylar 04

Figure 3 Kaplan-Meier Curves of Cumulative Rate of Relapse During the Double-Blind Treatment Period - vraylar 04

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.